Synjardy® (empagliflozin and metformin hydrochloride tablets)
for Diabetes Type 2

Synjardy (empagliflozin and metformin hydrochloride tablets) helps control blood sugar in type 2 diabetes. It removes excess glucose through the kidneys, reduces liver glucose production, and limits intestinal glucose absorption. Used with diet and exercise, it improves blood sugar control in patients 10 and older. It also lowers the risk of heart-related complications by enhancing insulin function and promoting glucose, salt, and water excretion.

Heart
Medication Guide Icon Medication Guide
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Diabetes Type 2